English | 中文

Absea is an antibody company established in 2001. We provide custom antibody services and antibody reagents world-wide for academic and industrial research purposes. Our major customers are from European countries and the North America. We have set up the ISO9001 quality management system since 2009.

The Board and Management:

Wei Zhang PhD is Chairman and Managing Director of Absea. Dr Zhang received PhD from Cambridge University and worked as a research associate at the Molecular Immunopathology Unit, MRC Centre in Cambridge before coming back to China. Dr Zhang is also a senior research scientist at the Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.

Frank Grosveld PhDFRS, is a Professor of Cell Biology and Genetics, Erasmus MC, Rotterdam, The Netherlands. He has been awarded the Louis-Jeantet Prize (1991) and the Spinoza Prize (1995) for his scientific contributions to the field of gene expression and is a founding board member of Harbour Antibodies BV.

Gang Xu PhD was graduated from the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. He worked as a senior scientist in Roche, Shanghai, and now he runs a therapeutic antibody company in Chengdu, China.

Weidong Yong PhD was graduated from the Institute of Botany, Chinese Academy of Sciences. He now is the senior research scientist at Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences.

Mr Lai Ho Un does import/export and manufacturing for technical and textile products. He has extensive business experience in China, Europe, USA, Asia, Middle East, Russia and Ukraine.


Roger Craig PhD has worked with start-up companies in the UK, Europe and China. Previously, he was Head of Biotechnology at ICI Pharmaceuticals and Professor of Biochemistry at the Middlesex Hospital Medical School (now University College London).

       © 2011 Absea Biotechnology Ltd. All rights reserved. Power by:010BEST  京ICP备11007005号  京公网安备110108003924号